Metrics to compare | ZIML | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZIMLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 193.6x | 29.1x | −0.4x | |
PEG Ratio | −3.12 | 0.13 | 0.00 | |
Price/Book | 2.4x | 3.8x | 2.6x | |
Price / LTM Sales | 1.8x | 3.2x | 3.1x | |
Upside (Analyst Target) | - | 14.2% | 49.0% | |
Fair Value Upside | Unlock | −1.9% | 7.0% | Unlock |
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was founded in 1984 and is based in Nagpur, India.